Cardiovascular Devices Market Growth Driven by Innovations in Diagnosis and Treatment

The research study on the Cardiovascular Devices market covers industry sectors, market climate, emerging innovations, competitive intelligence, and current developments in the industry. The sector study investigates the business dynamics of the rising economy, as well as current driving forces, market conditions, risks, trends, and problems. The analysis identifies the exact impact on the revenue and demand due to the disturbances caused by the occurrence of COVID-19. The recently launched growth strategies and development programs by the government and leading players in the market with the aim to impulse growth in the Cardiovascular Devices market are included in the report.

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐔𝐒𝐃 𝟓𝟖.𝟐𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟏𝟎𝟗.𝟐𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟑𝟑 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟖.𝟑%𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞 𝐭𝐨 𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞:

https://www.thehealthanalytics.com/request-sample/9

𝐌𝐚𝐢𝐧 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Abbott; GE HealthCare; Edwards Lifesciences Corporation; W. L. Gore & Associates, Inc.; Siemens Healthcare GmbH; BIOTRONIK SE & Co. KG; Canon Medical Systems Asia Pte. Ltd.; B. Braun SE; LivaNova PLC; Cardinal Health; Medtronic; Boston Scientific Corporation

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐥𝐨𝐩𝐦𝐞𝐧𝐭

November 2023 - Cardio Diagnostics Holdings and Vizient announced their partnership for AI cardiovascular tests.

February 2023 - Abbott announced its plans to acquire Cardiovascular Systems, Inc. (CSI) to expand its market presence in the cardiovascular space.

September 2022 - GE Healthcare introduced Optima IGS 320 - an AI-powered, made-in-India Cath lab to advance cardiac care in India.

July 2021 - Angel Medical Systems, Inc. announced the first commercial implantation of their flagship product, "The Guardian" device in the U.S. region. This was the first procedure followed by their recent FDA approval.

April 2021 - Phoenix Cardiac Devices, Inc. announced that they received a CE Mark for their product, BACE (Basal Annuloplasty of the Cardio externally) device. This approval helps in the commercialization of BACE in the European Union.

March 2021 - U.S. FDA announced the approval of the world's first non-surgical heart valve treatment for pediatric and adult patients suffering from a native or surgically repaired right Ventricular outflow tract (RVOT). The device was specifically developed to treat patients with severe pulmonary heart regurgitation.

𝐓𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

𝐁𝐲 𝐃𝐞𝐯𝐢𝐜𝐞 𝐓𝐲𝐩𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Therapeutic and Surgical Devices to Hold Dominant Share during the Forecast Period

Based on the device type, the market is segmented into diagnostic and monitoring devices, and therapeutic and surgical devices. The diagnostic and monitoring devices segment can be further sub-segmented into electrocardiogram (ECG), remote cardiac monitoring, and others. The therapeutic and surgical devices segment can be further sub-segmented into ventricular assist devices (VAD), cardiac rhythm management (CRM) devices, catheters, stents, heart valves, and others.

The therapeutic and surgical devices segment is anticipated to observe significant growth in the upcoming years due to the increasing number of local & regional players in the global market to serve the growing demand for advanced cardiac devices for therapeutic purposes. Furthermore, new product launches by major players would also drive the market.

For example, in December 2020, Abbott announced the launch of its clip-delivery system to treat patients suffering from mitral regurgitation. The diagnostic and monitoring devices segment is predicted to record a lower growth rate than the other segment but still has a considerable global market share.

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Coronary Artery Disease (CAD) Segment to Account for the Maximum Share

By applications, the global market is categorized into coronary artery disease (CAD), cardiac arrhythmia, heart failure, and others.

Coronary artery disease (CAD) has the highest revenue in 2023 and is anticipated to remain the dominant segment in the forecast period. This is primarily because a significant number of cardiovascular devices such as coronary stents are used to treat coronary artery disease (CAD) involving the narrowing of arteries which leads to other cardiac conditions such as heart attacks.

Cardiac arrhythmia is also expected to drive steady growth due to a surge in the adoption rate of pacemakers with futuristic technology to treat this condition. For instance, the Indian subsidiary of Medtronic launched the Azure pacemaker enabled with BlueSync technology. Heart failure cases are also expected to observe positive growth due to devices such as ventricular assist devices (VAD) for treating the disease.

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Hospitals Segment to Retain its Leading Position in the Forecast Period

By end user, the global market is segmented into hospitals, specialty clinics, and others. In terms of revenue, the hospitals segment is considered the leading segment in 2023, owing to the requirement of trained medical professionals to insert critical cardiovascular devices such as stents. Furthermore, hospitals also help in the reduction of adverse reactions in patients during critical medical procedures.

For example, the Cardiovascular Care Center at the Charlton Memorial Hospital announced that they had added a new electrophysiology lab. They also announced the complete renovation of the cardiac catheterization lab for elective as well as emergency treatments. Adding to it, specialty clinics are expected to be a rapidly growing segment during the forecast period with a comparatively significant CAGR.

Market Analysis and Insights: Global Cardiovascular Devices Market

Cardiovascular Devices Market report provides you with detailed insights, industry knowledge, market forecasts and analytics. The report on the global Cardiovascular Devices industry also clarifies economic risks and environmental compliance. Global market report assists industry enthusiasts including investors and decision makers to make confident capital investments, develop strategies, optimize their business portfolio, innovate successfully and perform safely and sustainably.

The report on the Cardiovascular Devices market covers the following region (country) analysis:

North America (the United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and the Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and the Rest of the Middle East & Africa)

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐓𝐎𝐂:

https://www.thehealthanalytics.com/research/cardiovascular-devices-market

Key takeaways from the Cardiovascular Devices Industry study

- Simplified and insightful comprehensive Cardiovascular Devices market analysis

- Evaluation of growth derivatives, crucial constraints, opportunities, and challenges

- Internal business overview including business connectivity, sales records, supply chain strategies and capabilities, product development, and marketing trends

- Exact Cardiovascular Devices industry valuation

- Future forecasts and Cardiovascular Devices market estimations followed by a demand to supply ratio projections

- Competitive benchmarking coupled with competitive analysis

- Key strategic initiatives fuelling Cardiovascular Devices market growth

- In-depth assessment of the product, application, and regional segments

- Neutral geographic survey based on macro and micro-economic factors highlighting the growth potential of developed and developing economies

𝐅𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐓𝐎𝐂 𝐨𝐟 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭:

Chapter 1: Cardiovascular Devices Market Overview

Chapter 2: Global Economic Impact on Industry

Chapter 3: Global Cardiovascular Devices Market Competition by Manufacturers

Chapter 4: Global Production, Profits (Value) by Region

Chapter 5: Global Supply (Production), Import, Export, Consumption, by Regions

Chapter 6: Global Price Trend by Type, Revenue (Value), Production

Chapter 7: Manufacturing Cost Analysis

Chapter 8: Global Market Analysis by Application

Chapter 9: Industrial Chain and Downstream Buyers, Sourcing Strategy

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Effect Factors Analysis

Chapter 12: Global Cardiovascular Devices Market Forecast

𝐊𝐞𝐲 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬:

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research and development (R and D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

We Offer Customization on Reports Based on Specific Client Requirements:

Client will get one free update on the purchase of Corporate User License.
Quarterly Industry Update for 1 Year at 40% of the report cost per update.
One dedicated research analyst allocated to the client.
Fast Query resolution within 48 hours.
Industry Newsletter at USD 100 per month per issue.
Thank you for taking the time to read our article…!!

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Analytica Global is a firm specializing in market research and consultancy services. Our primary objective is to assist our clients in tackling their most significant strategic and business-related challenges. We provide market research that not only helps clients navigate critical business problems, but also supports them in making informed business decisions with our evidence-based research, market insights,and precise data analysis.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞:

Analytica Global

Phone Number +1 (704) 266-3234

Email Address: sales@thehealthanalytics.com

This release was published on openPR.